Patient with Colorectal Metachronous Liver Metastases Associated with Extrahepatic Disease: Surgical Strategies

José Manuel Ramia Ángel, Roberto de la Plaza Llamas and José Edecio Quiñones Sampedro
Guadalajara University Hospital, Guadalajara, Spain

Series: Cancer Etiology, Diagnosis and Treatments
BISAC: MED062000

Clear

$0.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

Colorectal cancer (CRC) is the third most frequent neoplasm in the world, with an approximate incidence of 54 cases per 100,000 inhabitants in men and 34 per 100,000 in women. CRC is the second most frequent cause of death due to cancer in developed countries. Half of these patients develop hepatic metastasis in the course of the disease, 25% of them synchronously. The five-year survival of patients with CRC stage IV not treated surgically is 0-7%. Hepatic resection is considered to be the treatment of choice for colorectal liver metastases (CLM). (Imprint: Nova)

Preface

Introduction

Summary of Published Series of Patients with CLM and EHD

Extrahepatic Disease, By Organs

Conclusion

References

Index

You have not viewed any product yet.